Stock Analysis on Net

Moderna Inc. (NASDAQ:MRNA)

This company has been moved to the archive! The financial data has not been updated since November 3, 2023.

Statement of Comprehensive Income

Moderna Inc., consolidated statement of comprehensive income

US$ in millions

Microsoft Excel
12 months ended: Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Net income (loss) 8,362 12,202 (747) (514) (385)
Unrealized gains (losses) on available-for-sale debt securities (348) (42) 3 3
Net realized (gains) losses on available-for-sale securities reclassified to net income (loss) 26 (1) (1)
Net increase (decrease) from available-for-sale debt securities (322) (43) 1 3
Unrealized gains (losses) on derivative instruments 130 74
Net realized (gains) losses on derivative instruments reclassified to net income (loss) (154) (58)
Net increase (decrease) from derivatives designated as hedging instruments (24) 16
Other comprehensive income (loss), net of tax (346) (27) 1 3
Comprehensive income (loss) 8,016 12,175 (746) (511) (385)

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

Comprehensive income item Description The company
Net income (loss) The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Moderna Inc. net income (loss) increased from 2020 to 2021 but then slightly decreased from 2021 to 2022.
Comprehensive income (loss) Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Exclude changes in equity resulting from investments by owners and distributions to owners. Moderna Inc. comprehensive income (loss) increased from 2020 to 2021 but then slightly decreased from 2021 to 2022.